The intrinsic stimulatory potential or potency of a eukaryotic gene activator is controlled by the interaction between the activation domain and the transcriptional machinery. To further understand this interaction, we undertook a biochemical study to identify parameters that could be used to modulate activator potency. We considered how varying the number of activation domains, their flexibility, and the number of promoter sites affects potency in a yeast nuclear extract. The effects of GAL4 derivatives bearing either one, two, or four herpes simplex virus VP16 activation domains (amino acids 413 to 454) were measured on DNA templates containing one or two GAL4 sites in a Saccharomyces cerevisiae nuclear extract. We found that multimerized VP16 activation domains acted synergistically to increase the potency of the activators. The spacing between the activation domains was critical, such that the increased flexibility imparted by a protein linker contributed to increased activator potency. With highly potent activators, the levels of transcription stimulated on a single site were saturating, whereas the stimulatory effect of weaker activators increased with the number of sites. We discuss how these biochemical studies relate to the mechanism of gene activation and synergy in a yeast in vitro system.
Eukaryotic RNA polymerase II promoters bind a diverse group of proteins that regulate transcription initiation, either positively in the case of activators or negatively in the case of repressors. An active eukaryotic promoter contains a 2-million-dalton transcription initiation complex tethered to either the TATA box, the initiator element, or both (46) . The complex comprises, in addition to RNA polymerase II, eight or more ancillary factors that mediate basal transcription and allow the gene to respond to upstream activators (28, 46) . These ancillary factors and RNA polymerase are collectively referred to as the general transcription machinery. Evidence suggests that activators use a surface called the activation region to contact one or more targets in the general transcription machinery (28) to facilitate assembly of functional initiation complexes (15, 42) . The prototypic activation region, identified in the yeast activators GCN4 and GAL4 and the viral activator VP16, is defined by an abundance of acidic amino acids and a net negative charge (12, 18) . Other activation motifs that are rich in glutamine or proline have been mapped in both mammalian and Drosophila cells (20) .
Yeast nuclear extracts provide a biochemically tractable system to probe the mechanism of gene activation. Many GAL4-derived acidic activators have been shown to stimulate transcription in yeast extracts, and their relative potency parallels that observed in vivo (4) . The phenomenon of squelching (8) , whereby high concentrations of activator in solution compete with activators bound to DNA for limiting pools of transcription factors, was originally reproduced in yeast extracts. Squelching was used to identify molecules called mediators or adaptors, which presumably represent the direct targets of the activation region in yeast cells (1, 13) .
We were interested in determining what parameters controlled the activity of an activator in vitro in yeast extracts. This information would help us to understand the mechanism of gene activation and assist us in designing optimal yeast activators for further studies. In designing these activators, we reasoned that in many eukaryotic systems the magnitude of transcriptional activation is governed by two processes: synergy and activator potency. Synergy is when activators elicit a greater-than-additive transcriptional response from promoters bearing multiple sites. Synergy provides an organism with a means to differentially activate and regulate transcription by using either multiple molecules of a single activator (2, 3, 6) or different combinations of activators (14, 23, 33, 34) . Activator potency refers to the ability of a given activator to stimulate transcription and presumably reflects the affinity of the activation domain for its targets (28) , although this point has not been extensively investigated.
Several mammalian activators have been shown to contain multiple activation domains (21, 25, 36, 37, 39) , which in some instances act synergistically to increase the protein's potency (25, 36, 37) . In artificial situations, activation domains will act synergistically when multimerized (7, 11 To study the relationship between domain and site synergy biochemically, we used the well-characterized chimera GAL4-VP16, the activator used for the discovery of adaptors and mediators (1, 13) . GAILA-VP16 is a hybrid containing the 147-amino-acid GAL4 DNA binding domain fused to the 79-amino-acid acidic activation domain from VP16, a herpes simplex virus transactivator (31, 40) . The 79-amino-acid domain has been subdivided by deletion analysis into two smaller regions encompassing amino acids 411 to 456 (region 1) and 456 through 490 (region 2) (40); both individually appear to be weaker than the intact domain (3, 31) . Point mutations at critical hydrophobic positions within region 1, particularly at phenylalanine 442, abolish its activity (5, 29) . The key functional element in region 1 appears to be an 11-amino-acid segment encompassing this phenylalanine (35) . The entire activation domain, region 1, region 2, and the 11-amino-acid region 1 core element each activate transcription independently when fused to the GALA DNA binding domain (3, 7, 31, 35) .
In mammalian-cell transfection experiments, multimerization of VP16 region 1, and fusion to GAL4, led to a synergistic increase in activator potency on GAL4-responsive templates. This increase, however, was manifested only on a template bearing two upstream sites (3, 7) Ponticelli and Struhl (27) with the following modifications. Yeast spheroblasts were prepared in 60 ml of YPD containing 1 M sorbitol and 80 mg of Zymolyase 100T (Miles Laboratories, Inc.). The digestion was terminated by addition of 800 ml of ice-cold YPD in 1 M sorbitol, and then the spheroblasts were washed once in 800 ml of 1 M sorbitol. The nuclear pellet was isolated, frozen in liquid nitrogen, and stored at -80°C as described by Ponticelli and Struhl (27) . The nuclear pellet was extracted, and the final extract was resuspended in buffer C to a final concentration of 40 to 60 mg/ml and dialyzed against 4 liters of buffer C for 4 h (27) .
Plasmid constructs. The templates used in this study, GIE4T and G2E4T, have been described previously (3). The following GAL4 derivatives were described by Emami and Carey (7): GAL4-VP1, GAL4-VP2, GAL4-VP4, GAL4-XVP1, GAL4-AVP2, and GAL4-AVP4. GAL4-VP1, GAL4-VP2, GAL4-VP4, GAL4-XVP1, GAL4-XVP2, and GAL4-AVP4 were transformed into E. coli XA90.
Bacteria were grown at 37°C in 2 liters of Luria broth medium to an A600 of 0.5, induced with 1 mM IPTG, and grown for an additional 3 h at 37°C. The cells were harvested and lysed by sonication in buffer A (20 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid]-NaOH, pH 7.6, 50 mM 2-mercaptoethanol, 10 ,uM ZnCl2, 1 mM phenylmethylsulfonyl fluoride, 10 jg of pepstatin per ml, and 10 ,ug of leupeptin per ml) containing 0.2 M NaCl. The lysates were centrifuged at 16,000 x g for 10 min to remove insoluble material. Polyethyleneimine-HCl, pH 7.5, was added dropwise to each of the supernatants to a final concentration of 0.25%. After the mixture had been stirred for 10 min, the precipitates were collected by centrifugation at 10,000 x g for 10 min. Each pellet was dissolved in 50 ml of buffer A containing 0.75 M NaCl and resuspended by Dounce homogenization. After being gently stirred for 10 min, the mixtures were centrifuged as described above. The GALA derivatives were all present in the supernatants. Solid ammonium sulfate was added slowly to each of the supernatants to 35% saturation. After Figure 1A is a schematic representation of the fusion proteins used in our study. The GAL4 DNA binding domain GAL4(1-147), encompassing the first 147 amino acids of the protein, was fused to either one, two, or four copies of the VP16 activation region 1 (amino acids 413 to 454), each separated by a 2-amino-acid linker; we refer to the resulting proteins as GAL4-VP,, -VP2, and -VP4, respectively. The VP16 region 1 used here contains the 11-amino-acid functional core of the activation domain (35) . Note that because GAL4 binds its 17-bp recognition site as a dimer (19) , the activators contained twice the indicated number of activation domains. We also constructed a parallel set of clones in which the X repressor linker region (24) was introduced between the domains to increase spacing; these proteins were called GAL4-AVP1, -XVP2, and -XVP4, respectively. All of the GALA derivatives were overexpressed in E. coli by using a tac promoter expression vector (3, 4) and were purified as described in Materials and Methods. Figure 1B shows a Coomassie blue-stained SDS gel of the purified proteins. All seven proteins had essentially the same molar affinity for GALA binding sites in DNase I footprinting experiments (data not shown).
Transcriptional stimulation by GAL4-VP16 derivatives. The abilities of the GAL4 derivatives to stimulate transcription were compared with an S. cerevisiae nuclear extract (17, 27) (32) .
The product mRNAs from the in vitro transcription assays were measured by primer extension analysis. Figure 2A shows the results of a dose-response experiment. We Fig. 2A was scanned with a Pharmacia laser densitometer, and the amount of product (both clusters) was plotted as a line graph (Fig. 2B) . In the absence of activator, the signal was very weak (Fig. 2A, lane 1) . The graph shows that GAL4-VP1 stimulated transcription only marginally above the background levels. In contrast, peak concentrations of GAL4-VP2 stimulated 16 times more transcription than GAL4-VP1. Similarly, activation by GAL4-VP4 was three to four times stronger than that with GAL4-VP2. The stimulatory effects were highly reproducible in three independent experiments.
We considered the possibility that fusing the VP16 domains directly abutting one another might create steric problems that would reduce the efficacy of the interaction between the domains and their targets. We have previously shown this to be a problem when measuring the activities of GAL4-VP2 and GAL4-VP4 on a single-site template in mammalian cells (7) . Therefore, a derivative bearing a spacer region between the GAL4 DNA binding domain and the VP16 activation domain was tested. The spacer fragment was the 40-amino-acid linker separating the amino-and carboxy-terminal domains of the K repressor (24) . A schematic illustration of the fusion proteins containing the A linker is shown in Fig. IA .
When the A repressor linker was introduced between GAL4(1-147) and the VP16 activation domain (GAL4-XVP1), the ability to stimulate transcription increased significantly relative to that of GAL4-VP, (Fig. 2A , compare lanes 14 to 17 with lanes 2 to 5). The graph in Fig. 2B shows this difference to be about 12-fold at peak concentrations. We therefore introduced a single linker between each of the VP16 activation domains in the multimers. This manipulation also increased activator potency. For example, an activator containing two VP16 activation domains (GAL4-XVP2) separated by a linker was five times more active than GAL4-XVP, (Fig. 2B ) and four times more active than GAL4-VP2. The effect of GAL4-AVP4 was, however, comparable to that of GAL4-XVP2 (Fig. 2B) , suggesting that eventually transcription becomes saturated or nearly so. In each case, much weaker transcriptional stimulation was observed with addition of 100 ng of activator than with 10 or 30 ng. This squelching effect has been noted previously for the potent VP16 activation domain (31) . The stimulatory response is a direct consequence of the VP16 activation domains because neither GAL4(1-147) nor GAL4(1-147) fused to two copies of the X linker activated in the yeast extracts (data not shown). The addition of two linkers between the GAL4 DNA binding domain and the VP1 activation domain (GAL4-X2VP,) had little additional effect, as shown in Fig. 2C , and transcription was similar to the level elicited with GAL4-VP2 and GAL4-XVP, but below the level elicited with GAL4-XVP2. This result suggests that a single linker between the domains is sufficient to optimize efficacy.
Multimerizing the domains led to a synergistic increase in activator potency, as shown in Fig. 2D . The solid bar in each case represents the peak level of transcription elicited by an activator containing the lesser number of activation domains (from Fig. 2A) Figure 3A shows the results obtained when the activators were compared on templates bearing one and two sites.
Weaker activators, including GAL4-VP2 and GAL4-AVP,, all increased transcription (2.5-and 3.2-fold, respectively), but only marginally, when assayed on templates bearing two sites versus one site. In contrast, more potent activators such as of each activator. The reaction products were subjected to primer extension, and the resulting cDNAs were fractionated on a 10% polyacrylamide-7 M urea gel. An autoradiograph of the gel is shown. The primer and E4 extension products are indicated by arrows to the right of the autoradiograph. A schematic of the template is shown below the autoradiograph. A series of minor products migrated above the indicated products. These higher-molecular-weight products were induced to different extents in different extracts (see below). These may result from initiation downstream of TATA boxes present within GEM-3 vector DNA. If so, then the GAL4 derivatives must be activating transcription from these TATA boxes from a downstream position. Our attempts to perform a similar experiment in a mammalian in vitro system were hampered by the strong squelching potential of the multi-VP16 fusion proteins (data not shown). Prods.
a u nt e Primer GAL4-VP4, GAL4-XVP2, and GAL4-XVP4 elicited approximately the same levels of transcription on both templates. Figure 3A also shows a comparison of the different activators alongside a dose-response titration of GAL4-VP16 containing an intact 79-amino-acid activation region (amino acids 411 to 490) rather than the truncated variant used as described above. The data show that at optimal concentrations, the intact VP16 domain on a single site is more potent than GAL4-VP1, GAL4-VP2, or GAL4-XVP1 but less potent than GAL4-VP4, GAL4-XVP2, or GAL4-XVP4. Thus, multimerizing region 1 creates an activator stronger than the original intact VP16 domain. The results were consistent in three independent experiments. Figure 3B shows that the transcriptional effects shown in Fig. 3A could be observed under conditions in which the sites were saturated as determined by DNase I footprinting analysis, demonstrating that the differences in activity were not due to differences in affinity on either the one-or two-site DNA template. The key finding, however, was that weaker activators elicit at best additive or weakly synergistic effects from multiple sites, while stronger activators apparently mediate full, saturated levels of transcription from a single site in vitro. The saturation is not due to titration of a limiting factor because increasing the concentration of template DNA led to a proportional increase in the bulk level of transcription. Figure 3C shows the effect of distance on the relative activities of the different activators. With GAL4-VP1, -VP2, Templates bearing one and two GAL4 sites (GIE4T and G2E4T) were incubated with peak amounts of the indicated GAL4 derivatives as determined by a dose-response experiment similar to that shown in Fig. 2 . Transcription was measured by primer extension. An autoradiograph of the gel is shown. Although it is not apparent in this exposure, the basal levels of transcription are the same on both templates. (B) DNase I footprint reaction performed in yeast nuclear extract. A 32P-labeled DNA fragment encompassing either G1E4T or G2E4T was preincubated in the nuclear extract under transcription conditions with no added protein (-) or the concentrations of the indicated GAL4 derivatives which elicited the peak levels of transcription depicted in Fig. 2B and the peak amounts of synergy shown in Fig.  2D . After 20 min, the mixtures were treated with DNase I and the purified products were fractionated on a 40-cm-long sequencing gel. An autoradiograph of the gel is shown. (C) Transcriptional effects of GAL4-VP1, -VP2, and -VP4 positioned various distances from the TATA box. G5E4T contains five tandem GAL4 sites 23 bp upstream of the E4 TATA box. G5I54E4T and G51201E4T contain further insertions of 54 and 201 bp, respectively. -, no added protein; Ext. Prods., extension products. and -VP4, approximately the same relative activities could be observed on G5E4T when the sites were either 23, 77 (G5154E4T), or 224 (G51201E4T) bp upstream from the TATA box, although the activity decreased dramatically going from 77 to 224 bases away, as we have shown previously with a mammalian in vitro system. A similar decrease was observed previously in the yeast system with GAL4-VP16 (4) . Thus, GAL4-VP4 was always more potent than GAL4-VP, at all distances tested. At 224 bp, however, GAL4-VP2 and GAL4-VP4 appeared to elicit similar levels of activation. We conclude that the positioning of the GALA sites does not significantly alter the relative potency of the activators.
DISCUSSION
Speculations on the mechanism of synergy in vitro. The oyerall goal of this study was to determine whether site and domain synergy exist in a yeast in vitro system and how these phenomena contributed to the overall potency of the activator. We demonstrated that multimerization of the VP16 activation domains led to a synergistic increase in gene activation in an S. cerevisiae nuclear extract. Cooperative DNA binding is one mechanism to achieve synergistic gene activation in both yeast and mammalian cells (9, 41, 45 (Fig. 2C) 4. This might suggest a difference in the manner in which yeast and mammalian cells utilize synergy. However, the relevance of this speculation must be regarded with caution, as the discrepancy may be due not to physiological differences between yeast and mammalian cells but to differences between the yeast extract and the in vivo situations.
It is also possible that the lack of site synergy in the extracts is due to an absence of nucleosomes or proteins that act on them (26) . Because no special care is taken to assemble our templates into chromatin, we find it unlikely that they form chromatin in the extract. Hence, any effects attributed to chromatin would not be detected. GAL4 derivatives have been shown to bind cooperatively to nucleosomal templates in a mammalian in vitro system (38, 44) .
Comparison with other studies. Recent studies have emphasized similarities in the modular organization of mammalian promoters and activation domains: promoters and enhancers are composed of multiple activator-binding sites that generate a synergistic transcriptional response (23, 33) , while many activators comprise multiple activation regions that also elicit synergistic effects (11, 21, 25, 36, 37, 39) . It has been previously documented that the number of upstream activator sites can influence the yeast transcription levels in either an additive or a synergistic manner (9, 22) . This study shows that in a yeast extract, an activation domain can act as a functional module to synergistically increase the strength of the activator. The fact that a single module is active, albeit marginally, argues that the synergy is not the result of creating a functional activation region from inactive parts but is instead an energetic effect on the efficiency of the reaction. The synergistic effect of multimerizing an active unit differs from results obtained in a study on dissection of the GCN4 activation region (12) . In that study, the activation region appeared to be composed of short, tandem, functional repeats, which contributed in an additive manner to activator potency.
Our ability to observe domain synergy, but only weak site synergy, apparently conflicts with what was observed in at least one study performed in vivo. Oliviero and Struhl (22) used Fos-Jun heterodimers to deliver either one or two acidic VOL. 14, 1994 on February 21, 2013 by PENN STATE UNIV http://mcb.asm.org/ GCN4 activation domains to templates bearing one or two upstream AP-1 sites. On one site the two domains were relatively inactive, whereas on two sites the domains elicited a synergistic transcriptional response. This result led to the conclusion that only site synergy could be observed in vivo. However, the authors did not measure site occupancy in vivo to eliminate the possibility that the activators were not binding cooperatively to the sites there. Cooperative binding to chromatin templates has been invoked as one possible mechanism for synergistic activation in vivo (38, 44) . Nor did the authors try to use protein linkers to mimic the increased spacing and flexibility imparted by the DNA. Nevertheless, our results must be interpreted cautiously in view of the uncertainty concerning how faithfully the yeast in vitro system reproduces yeast physiology.
